Novavax (NVAX) Stock Dips Amidst Volatility in Biotech Sector

Shares of Novavax (NVAX, Financial), a biotechnology firm specializing in vaccine development, experienced a significant drop of 5.11%. The stock is currently priced at $12.92 with a trading volume of approximately 3.03 million shares, reflecting a turnover rate of 1.89$415 million, net earnings of $162 million, and earnings per share of$1.09. The company's gross profit stands at $379 million, with a price-to-ea ...